Danaher Corporation logo
Danaher Corporation (DHR)
Compare

Danaher Corporation (DHR) PEG Ratio: 89.17

Is Danaher Corporation’s PEG ratio high or low?

Danaher Corporation's PEG ratio of 89.17 is 4569% above its 5-year average of 1.91, near the high end of its 5-year range (0.42–4.32).

The PEG ratio for Danaher Corporation (DHR) is 89.17. It is above its 12-month average by 7239.09% (1.21).

DHR PEG Ratio Chart

DHR PEG Ratio
2.01+378.57% 1Y
Zoom

DHR Average PEG Ratio Chart

DHR Current vs Average PEG Ratio Chart

DHR PEG Ratio Metrics

PEG RATIO

89.17

PEG RATIO AVG TTM

1.21

PEG RATIO AVG 3Y

1.11

PEG RATIO AVG 5Y

1.91

PEG RATIO AVG 10Y

1.55

PEG RATIO AVG 15Y

1.24

PEG RATIO AVG 20Y

1.01

CURRENT VS TTM AVG

+7239.09%

CURRENT VS 3Y AVG

+7957.53%

CURRENT VS 5Y AVG

+4568.59%

CURRENT VS 10Y AVG

+5668.85%

CURRENT VS 15Y AVG

+7096.93%

CURRENT VS 20Y AVG

+8697.60%

DHR Competitors' PEG Ratio

NAMEMARKET CAPPEG RATIOTTM3Y5Y
Danaher Corporation (DHR)89.171.211.111.91
CVS Health Corporation (CVS)$125.16BN/A0.131.201.16
Bristol-Myers Squibb Company (BMY)$114.14B1.670.240.240.18
Pfizer Inc. (PFE)$146.36BN/A0.070.130.16
Intuitive Surgical, Inc. (ISRG)$146.44B3.173.022.602.27
Vertex Pharmaceuticals Incorporated (VRTX)$110.77B1.692.581.901.47
Gilead Sciences, Inc. (GILD)$151.21B0.010.010.380.25
Abbott Laboratories (ABT)$154.66B3.010.110.360.87
Medtronic plc (MDT)$103.04B6.733.743.742.73
Elevance Health Inc. (ELV)$87.43B2.576.994.823.75

Growth-Adjusted Valuation

PEG Ratio

89.17

P/E Ratio

35.7

Danaher Corporation PEG Ratio Formula & Definition

PEG Ratio = PE Ratio / Earnings Growth Rate

The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Danaher Corporation PEG Ratio FAQ

What is the PEG ratio for Danaher Corporation (DHR)?
The PEG ratio for DHR stock is 89.17.
Is Danaher Corporation's PEG ratio high or low?
Danaher Corporation's PEG ratio of 89.17 is 4569% above its 5-year average of 1.91, near the high end of its 5-year range (0.42–4.32).
What is the TTM average PEG ratio for Danaher Corporation (DHR)?
The TTM average PEG ratio for DHR stock is 1.21.
What is the 3Y average PEG ratio for Danaher Corporation (DHR)?
The 3Y average PEG ratio for DHR stock is 1.11.
What is the 5Y average PEG ratio for Danaher Corporation (DHR)?
The 5Y average PEG ratio for DHR stock is 1.91.
What is the 10Y average PEG ratio for Danaher Corporation (DHR)?
The 10Y average PEG ratio for DHR stock is 1.55.
What is the 15Y average PEG ratio for Danaher Corporation (DHR)?
The 15Y average PEG ratio for DHR stock is 1.24.
What is the 20Y average PEG ratio for Danaher Corporation (DHR)?
The 20Y average PEG ratio for DHR stock is 1.01.

Danaher Corporation PEG Ratio History

DATEPEG RATIO
2022-12-312.01
2021-12-310.42
2020-12-310.89
2018-12-314.32
2015-12-310.56
2013-12-311.10
2012-12-311.52
2011-12-310.63
2010-12-310.22
2007-12-310.72
2006-12-310.54
2005-12-310.62
2004-12-310.43
2003-12-310.21
2000-12-310.84
1999-12-310.50
1998-12-319.20
1996-12-310.11

About Danaher Corporation

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Washington, DC
61,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Rainer Blair